Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Anti-estrogenic Therapy in Breast Cancer Patients on Brain Architecture, Psychosexual Health, and Quality of Life

NCT06346457 is registered in ClinicalTrials.gov with International Research Training Group 2804 as lead sponsor.

NCT NCT06346457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06346457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Anti-estrogenic Therapy in Breast Cancer Patients on Brain Architecture, Psychosexual Health, and Quality of Life
Lead sponsor
International Research Training Group 2804
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2024
Completion date
April 1, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-estrogenic therapy, breast cancer female, healthy female, menopause